1. Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSThe task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio- Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–60
2. Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, et al. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the working group on antiplatelet drugs resistance appointed by the section of cardiovascular interventions of the polish cardiac society, endorsed by the working group on thrombosis of the European society of cardiology. Eur Heart J. 2009;30(4):426–35
3. Warlo E, arnesen H, Seljeflot I. A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease. Thrombosis Journal (2019) 17:11
4. Cattaneo M. 2013. High on-treatment platelet reactivity – definition and measurement. Thrombosis and Haemostasis 109.5/2013
5. Paniccia R., Priora R., Liotta A.A., Abbate R. 2015. Platelet function tests: a comparative review. Vascular Health and Risk Management, 11;133–148.
6. Aradi D, Storey RF, Komocsi A, Trenk D, Gulba D, Kiss RG, et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J. 2014;35(4): 209–15.
7. Lawton JS, Tamis-Holland JE,et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9. Erratum in: Circulation. 2022 Mar 15;145(11):e771. PMID: 34882436.
8. Neumann F, Sousa M, Ahlsson A et al. 2018 ESC/EACTS Guidelines of myocardial revascularization supplementary data. European Heart Journal (2018) 00, 1–23
9. Yu LH, Kim MH, Zhang HZ, et al. Impact of platelet function test on platelet responsiveness and clinical outcome after coronary stent implantation: platelet responsiveness and clinical outcome. Korean Circ J. 2012;42(6):382-389. doi:10.4070/kcj.2012.42.6.382
10. Hidayati F, Irawan B, Mumpuni H. Aspirin and Clopidogrel Resistance in Coronary Artery Disease. Acta Cardiologia Indonesiana (Vol 3 No. 1): 33-44.
11. Alegria-Barrero E. 2010. Platelet reactivity tests: why they are useful and which ones to use. www.escardio.org/Guidelines-&-Education/Journals-and-publications/ESCjournals-family/E-journal-of-CardiologyPractice/Volume-8/Platelet-reactivity-testswhy-they-are-useful-and-which-ones-touse
12. Neubauer, H., Kaiser, A.F., Endres, H.G. et al. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med 9, 3 (2011). https://doi.org/10.1186/1741-7015-9-3
13. Hidayat R, Nabilah RA, et al. Clopidogrel Resistance Among Ischemic Stroke Patients and Its Risk Factors in Indonesia. Acta Med Acad. 2022 Apr;51(1):29-34. doi: 10.5644/ama2006-124.367. PMID: 35695400.